Immune Checkpoint Inhibitors — The Need for Innovation

P. Connor Johnson, Justin F. Gainor, Ryan J. Sullivan, Dan L. Longo, Bruce A. Chabner

New England Journal of Medicine · 2023 · 49 citations · 10 references

Concepts

Abstract

Immune checkpoint inhibitors represent a major advance in the treatment of cancer. The authors argue that future efforts should focus less on redundant agents and more on new approaches to immunotherapy.

References

10